OPUS GENETICS, INC. (IRD)
Opus Genetics Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients with Inherited Retinal Diseases
Opus Genetics Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients with Inherited Retinal Diseases
AMC Global Media Appoints Hozefa Lokhandwala as Chief Financial Officer
CareTrust REIT Announces Quarterly Dividend of $0.39 per Share
Highwoods to Release Second Quarter 2026 Results Tuesday, July 28th
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Rigel Announces Closing of Licensing Agreement forVEPPANU™ (vepdegestrant)
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acquisition of Own Shares
Verastem Oncology Doses First Patient in TARGET-D 201 Phase 2 Registration-Directed Trial of VS-7375 Oral KRAS G12D (ON/OFF) Inhibitor for KRAS G12D-Mutated Metastatic Pancreatic Cancer
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)